Page last updated: 2024-10-22

amobarbital and Premenstrual Syndrome

amobarbital has been researched along with Premenstrual Syndrome in 2 studies

Amobarbital: A barbiturate with hypnotic and sedative properties (but not antianxiety). Adverse effects are mainly a consequence of dose-related CNS depression and the risk of dependence with continued use is high. (From Martindale, The Extra Pharmacopoeia, 30th ed, p565)
amobarbital : A member of the class of barbiturates that is pyrimidine-2,4,6(1H,3H,5H)-trione substituted by a 3-methylbutyl and an ethyl group at position 5. Amobarbital has been shown to exhibit sedative and hypnotic properties.

Premenstrual Syndrome: A combination of distressing physical, psychologic, or behavioral changes that occur during the luteal phase of the menstrual cycle. Symptoms of PMS are diverse (such as pain, water-retention, anxiety, cravings, and depression) and they diminish markedly 2 or 3 days after the initiation of menses.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
ROGERS, J1
Mettler, L1
Sadighi, R1

Reviews

1 review available for amobarbital and Premenstrual Syndrome

ArticleYear
MENSTRUAL DISORDERS.
    The New England journal of medicine, 1964, Feb-13, Volume: 270

    Topics: Amobarbital; Dextroamphetamine; Diethylstilbestrol; Dysmenorrhea; Estradiol; Estrogens, Conjugated (

1964

Other Studies

1 other study available for amobarbital and Premenstrual Syndrome

ArticleYear
[Gynecologic-obstetric pain therapy. Use of Lonarid N].
    ZFA. Zeitschrift fur Allgemeinmedizin, 1980, Feb-20, Volume: 56, Issue:5

    Topics: Acetaminophen; Adolescent; Adult; Amobarbital; Caffeine; Codeine; Drug Combinations; Dysmenorrhea; E

1980